查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1976176

脑血管造影术市场：按装置类型、操作模式、应用和最终用户划分－2026-2032年全球预测

Cerebral Angiography Market by Equipment Type, Operation Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脑血管造影术市场价值将达到 59.8 亿美元，到 2026 年将成长至 63.7 亿美元，到 2032 年将达到 94 亿美元，复合年增长率为 6.67%。

主要市场统计数据
基准年 2025 59.8亿美元
预计年份：2026年 63.7亿美元
预测年份 2032 94亿美元
复合年增长率 (%) 6.67%

对现代血管造影术医学中影像学和介入治疗的目的、临床重要性和整合的权威观点。

脑血管造影术在现代神经血管医学中发挥核心作用，因为它能够直接观察颅内和颅外血管结构，从而进行诊断和治疗性介入。即使影像技术不断进步，这项技术在包括急性中风治疗、动脉瘤检测和治疗方案製定、血管畸形评估以及复杂介入神经放射学手术在内的多种临床场景中仍然至关重要。诊断清晰度和操作便利性之间的平衡是临床决策的基础，也推动着对设备设计和影像软体的持续投入。

快速的技术进步、流程优化和不断发展的治疗路径是如何重塑脑血管造影术的实践和采购趋势的？

脑血管造影术领域正经历一场变革，这场变革的驱动力来自于技术进步、流程通讯协定的完善以及医疗体系的重组。数位影像处理和即时处理技术的进步使得高解析度血管造影术成为可能，同时降低了辐射剂量，从而直接影响手术安全性和临床实践。除了硬体创新之外，软体的改进（特别是自动化、血管分割和三维重建）也提高了手术效率，并支援在复杂介入手术中实现更精准的导航。

对美国在 2025 年实施的关税措施对脑血管造影术。

美国在2025年实施和调整的关税将对脑血管血管造影术生态系统产生累积影响，其影响远不止于即时的成本问题。关税压力将增加进口成像组件、检测器、精密导管及相关耗材的到岸成本，迫使采购团队重新评估其供应商组合。为此，一些製造商正在探索本地化生产、认证国内供应商或重新设计供应链，以减少对关税敏感型供应链的依赖。虽然这些调整需要时间和投资，但最终可以增强企业应对贸易政策波动的能力。

根据设备类型、操作模式、临床应用和最终使用者环境的不同，不同的策略需求会影响技术采用和采购决策。

基于细分市场的分析突显了技术采纳、营运需求和最终用户优先顺序的关键差异。设备类型分为固定式和移动式。固定式系统通常安装在专用血管造影术室，优先考虑持续高吞吐量、先进的软体模组以及与外科和重症监护团队的协作。而行动装置则优先考虑便携性、在混合手术室的快速部署以及跨多个治疗区域的灵活排班。基于运行模式的分类分析了类比和数位市场。虽然类比平台仍在一些传统环境中运作，但由于其卓越的影像处理、剂量管理以及与电子健康记录的无缝集成，数位系统在新投资中占据主导地位。基于应用的分类分析了诊断和治疗性介入应用领域的市场。诊断应用优先考虑用于病灶表征的影像清晰度和工作流程效率，而治疗性介入应用则需要强大的设备相容性、先进的导航工具和即时影像处理能力来支援治疗程序。最终使用者分为门诊手术中心和医院。医院又进一步细分为私立医院和公立医院。门诊手术中心正在拓展针对特定手术的门诊干预项目，私立医院也经常投资先进技术以支持其高水准的急诊网路。另一方面，公立医院则需要在广泛的医疗服务覆盖范围和有限的资本预算之间寻求平衡，优先考虑建造持久耐用且易于维护的系统以应对大量的患者。

主要地区医疗保健模式和基础设施的差异如何影响采购重点、临床部署和供应商策略。

区域趋势影响着三大关键区域的采购重点、法规环境和临床应用模式。在美洲，医疗保健系统通常专注于整合网路和快速中风转诊途径，这有利于投资建造高通量血管造影术室，并促进急诊医学、神经病学和介入治疗团队之间的密切合作。报销机制和资本规划实践鼓励将先进服务集中在指定的卓越中心，同时扩大门诊低复杂度介入治疗的病例范围。

对于那些优先考虑透过模组化硬体和软体简化临床工作流程和提高服务品质的供应商而言，深化与医疗保健提供者的伙伴关係是一项关键的竞争挑战。

脑血管造影术领域企业的竞争主要体现在影像硬体的创新、软体主导的工作流程改进以及能够降低供应商整体拥有成本的综合服务模式。主要企业优先采用模组化系统结构，实现检测器和处理单元的分阶段升级，进而延长设备使用寿命，减少系统整体更换的需求。同时，从自动血管分割到手术规划和整合报告等软体功能，正成为影响采购决策和长期供应商合作关係的关键差异化因素。

产业相关人员可以实施切实可行的策略措施，以增强供应链韧性、加速数位化能力发展并加强临床伙伴关係。

产业领导者可以采取果断行动，以维持临床意义和营运韧性。首先，他们应优先考虑供应链多元化和关键零件的双重采购，以减轻贸易政策变化和单一故障点的影响。投资于区域製造伙伴关係和灵活的物流系统将有助于缩短前置作业时间并提高服务的可预测性。其次，他们应透过整合互通性标准来加速整个影像平台的数位转型，从而实现高级影像处理、剂量优化以及无缝的电子健康记录连接和治疗报告。

严谨的混合调查方法，结合文献综述、监管审查、专家访谈和比较工具分析，确保了扎实的实务知识。

本研究整合了同侪审查临床文献、监管申报文件、医疗设备技术规范和公共政策文件的系统性综述证据，并辅以对介入神经放射学医师、放射科主任、医疗设备技术人员和采购负责人的结构化访谈。为确保临床准确性和相关性，资料收集优先获取最新的手术指南、医疗设备安全建议以及影像引导介入的同侪审查分析。受访者的选择旨在代表门诊手术中心和医院环境中各类最终用户，从而能够对营运挑战和推广驱动因素进行三角验证。

本文简明扼要地总结了技术进步、供应链的韧性和细分市场策略如何整合起来，为脑血管血管造影术的维护和发展做出贡献。

脑血管血管造影术兼具诊断准确性与治疗能力，是现代神经血管医学的基石。数位影像、软体辅助工作流程和导管设计等方面的技术进步，使得手术更加安全高效，并拓展了血管造影术的临床应用范围。然而，贸易政策的变化和区域基础设施的差异等外部压力，凸显了高度灵活的供应链和服务模式的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：脑血管造影术市场：依设备分类

  • 固定的
  • 移动的

第九章：血管造影术市场运作模式划分）

  • 模拟
  • 数位系统

第十章：脑血管血管造影术市场：依应用领域划分

  • 诊断
  • 介入治疗

第十一章：脑血管血管造影术市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院

第十二章：脑血管血管造影术市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：脑血管血管造影术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：脑血管血管造影术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国脑血管血管造影术市场

第十六章：中国脑血管血管造影术市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Cook Group Incorporated
  • GE Healthcare Technologies Inc.
  • Guerbet SA
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • InterMed Medical Limited
  • Koninklijke Philips NV
  • MEDTRON AG
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • St. Stone Medical Devices Private Limited
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-8E22B619330B

The Cerebral Angiography Market was valued at USD 5.98 billion in 2025 and is projected to grow to USD 6.37 billion in 2026, with a CAGR of 6.67%, reaching USD 9.40 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.98 billion
Estimated Year [2026] USD 6.37 billion
Forecast Year [2032] USD 9.40 billion
CAGR (%) 6.67%

An authoritative orientation to cerebral angiography objectives, clinical importance, and the convergence of imaging and interventional care in modern neurovascular practice

Cerebral angiography occupies a central role in modern neurovascular medicine by enabling direct visualization of intracranial and extracranial vasculature for both diagnosis and intervention. As imaging modalities evolve, the procedure maintains clinical relevance across acute stroke management, aneurysm detection and treatment planning, vascular malformation assessment, and complex neurointerventional procedures. The interplay between diagnostic clarity and procedural access underpins clinical decision-making and continues to drive investments in both device design and imaging software.

Clinicians value cerebral angiography for its spatial and temporal resolution and for the therapeutic window it provides when interventional approaches are indicated. Innovations in catheter technology, contrast media protocols, x-ray detector sensitivity, and digital image processing have collectively improved procedural safety and efficacy. Consequently, hospital systems and ambulatory surgical centers are recalibrating care pathways to integrate angiographic capabilities into stroke hubs and tertiary neurovascular centers, thereby enabling faster triage and more precise therapeutic delivery.

How rapid technological advances, procedural optimization, and evolving care pathways are reshaping cerebral angiography practice and procurement dynamics

The cerebral angiography landscape is in the midst of transformative shifts driven by technological progress, procedural protocol refinement, and health system-level reconfiguration. Advances in digital imaging and real-time processing now enable higher-resolution angiographic runs with lower radiation dose, which has immediate implications for procedural safety and operator practice. Parallel to hardware innovation, software enhancements-particularly in automation, vessel segmentation, and three-dimensional reconstructions-are increasing procedural efficiency and supporting more accurate navigation during complex interventions.

Beyond technology, clinical pathways have adjusted in response to the pressing need for faster reperfusion in ischemic stroke, leading to more integrated triage systems and streamlined transfer protocols between facilities. These operational changes increase demand for nimble angiography solutions that can be deployed across a range of settings while maintaining high-quality imaging. At the same time, regulatory emphasis on patient safety and device interoperability is prompting manufacturers to prioritize modular, upgradable architectures and to pursue certifications that facilitate cross-platform compatibility. Collectively, these shifts are reshaping investment priorities among providers and influencing procurement strategies across the care continuum.

Assessing the systemic consequences of United States tariff measures in 2025 on cerebral angiography supply chains, procurement behavior, and clinical continuity

The introduction and adjustment of tariffs by the United States in 2025 exert cumulative effects on the cerebral angiography ecosystem that extend beyond immediate cost implications. Tariff pressures raise the landed cost of imported imaging components, detectors, precision-engineered catheters, and ancillary disposables, which prompts procurement teams to reassess supplier portfolios. In turn, some manufacturers respond by seeking localized production, qualifying domestic suppliers, or redesigning supply chains to reduce exposure to tariff-sensitive nodes. These adaptations take time and investment but can ultimately increase resilience to trade policy volatility.

Operationally, facilities face extended lead times and potential substitution of components when preferred parts become subject to higher import duties. Clinicians and biomedical engineering teams must weigh the tradeoffs between short-term availability and long-term performance when selecting alternatives. Meanwhile, policy responses from trading partners and shifts in bilateral trade agreements can influence the flow of medical devices and components, adding another layer of uncertainty. In response, leading suppliers are accelerating dual-sourcing strategies and expanding regional distribution footprints to mitigate the cumulative effects of tariffs on clinical continuity and device support.

Differentiated strategic imperatives driven by equipment type, operation mode, clinical application, and end-user settings shaping technology adoption and procurement decisions

Segmentation-driven insight highlights meaningful differences in technology adoption, operational requirements, and end-user priorities. Based on Equipment Type, market is studied across Fixed and Mobile; Fixed systems, typically installed in dedicated angiography suites, emphasize sustained high throughput, advanced software modules, and integration with surgical and critical care teams, whereas Mobile units prioritize portability, rapid deployment within hybrid operating rooms, and flexible scheduling across multiple procedural areas. Based on Operation Mode, market is studied across Analog and Digital; analog platforms remain in service in some legacy environments but digital systems dominate new investments due to superior image processing, dose management, and seamless integration with electronic health records. Based on Application, market is studied across Diagnostic and Interventional; diagnostic use cases prioritize image clarity and workflow efficiency for lesion characterization, while interventional applications demand robust device compatibility, advanced navigation tools, and real-time imaging capabilities to support therapeutic maneuvers. Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals. The Hospitals is further studied across Private Hospitals and Public Hospitals; ambulatory surgical centers increasingly pursue outpatient interventional programs for selected procedures, private hospitals often invest in premium technology to support high-acuity referral networks, and public hospitals balance broad access with constrained capital planning, prioritizing durable, serviceable systems that support high patient volumes.

These segmentation perspectives reveal that procurement criteria differ across settings: fixed, high-volume suites favor system longevity and advanced imaging suites, while mobile and ambulatory contexts value compact footprint and rapid setup. Similarly, digitalization and interventional use cases accelerate demand for software-enabled workflows and vendor-supported training. Understanding these segmentation-based distinctions enables suppliers and providers to align product development, service models, and clinical training to the nuanced needs of each end-user type.

How distinct regional healthcare models and infrastructure variations across key geographies influence procurement priorities, clinical adoption, and supplier strategies

Regional dynamics influence procurement priorities, regulatory environments, and clinical utilization patterns across three broad geographies. In the Americas, health systems often focus on integrated networks and rapid stroke referral pathways, which incentivize investment in high-throughput angiography suites and close coordination between emergency medicine, neurology, and interventional teams. Reimbursement structures and capital planning practices encourage consolidation of advanced services in designated centers of excellence while ambulatory settings expand case portfolios for lower-complexity interventions.

In Europe, Middle East & Africa, the landscape presents heterogeneity driven by varied regulatory regimes, public versus private funding models, and infrastructure disparities. Many urban tertiary centers in this region pursue cutting-edge imaging upgrades and interventional program expansion, while regions with constrained resources prioritize durable platforms and remote support capabilities. In the Asia-Pacific region, rapid adoption of digital imaging, increasing investment in tertiary neurovascular programs, and a growing emphasis on domestic manufacturing and regulatory harmonization are notable trends. Across regions, suppliers adapt distribution and support strategies to meet differing clinical protocols, regulatory timelines, and capital procurement cycles, thereby shaping how technologies diffuse into practice.

Key competitive priorities for vendors emphasizing modular hardware, software-enabled clinical workflows, and service excellence to deepen provider partnerships

Competitive dynamics among companies servicing the cerebral angiography domain center on innovation in imaging hardware, software-driven workflow enhancements, and comprehensive service models that reduce total cost of ownership for providers. Leading firms increasingly prioritize modular system architectures that allow iterative upgrades to detectors and processing units, which supports longer equipment lifecycles and mitigates the need for full-system replacements. At the same time, software capabilities-ranging from automated vessel segmentation to procedural planning and integrated reporting-have become differentiating features that influence purchasing decisions and long-term vendor relationships.

Strategic partnerships between device manufacturers, software developers, and clinical centers are accelerating the translation of research into practice, enabling early validation of novel image-guided techniques. Service offerings that combine preventive maintenance, remote diagnostics, and expedited parts logistics are also central to company positioning, particularly for customers balancing procedural volume with constrained capital budgets. Overall, firms that demonstrate interoperability, robust clinical evidence, and responsive service networks tend to secure deeper integration within provider ecosystems and maintain stronger post-sale engagement.

Practical, high-impact strategic moves that industry stakeholders can implement to enhance supply resilience, accelerate digital capabilities, and strengthen clinical partnerships

Industry leaders can take decisive steps to sustain clinical relevance and operational resilience. First, prioritize supply chain diversification and dual-sourcing for critical components to reduce exposure to trade policy shifts and single points of failure. Investing in regional manufacturing partnerships and flexible logistics arrangements will shorten lead times and improve service predictability. Second, accelerate digital transformation across imaging platforms by integrating advanced image processing, dose optimization, and interoperability standards that facilitate seamless electronic health record connectivity and procedural reporting.

Third, align product development with evolving clinical workflows by supporting both diagnostic clarity and interventional utility; systems that bridge these needs will better serve integrated stroke and neurovascular programs. Fourth, strengthen post-sale relationships through outcome-focused service offerings, including remote monitoring, predictive maintenance, and clinician training programs that shorten learning curves for advanced procedures. Finally, engage proactively with health policy stakeholders to clarify regulatory pathways and to design reimbursement strategies that reflect the value of image-guided intervention, thereby enabling more sustainable adoption across diverse healthcare settings.

A rigorous, mixed-methods research approach combining literature, regulatory review, expert interviews, and comparative device analysis to ensure robust and actionable insights

This research synthesizes evidence from a systematic review of peer-reviewed clinical literature, regulatory filings, device technical specifications, and publicly available policy documents, supplemented by structured interviews with practicing neurointerventionalists, radiology department leaders, biomedical engineers, and procurement professionals. Data collection prioritized recent procedural guidelines, device safety advisories, and peer-reviewed analyses of image-guided interventions to ensure clinical accuracy and relevance. Interview subjects were selected to represent a cross-section of end users across ambulatory surgical centers and hospital settings, enabling triangulation of operational challenges and adoption drivers.

Analytic methods combined qualitative thematic analysis of interview data with comparative evaluation of device features and post-market surveillance reports. Segmentation frameworks were applied to evaluate how equipment type, operation mode, application, and end-user setting influence procurement criteria and clinical workflows. Throughout the research process, findings underwent independent expert validation to ensure robustness, and limitations related to data availability and regional heterogeneity were explicitly documented to guide interpretation and application of the insights.

A concise synthesis of how technological progress, supply resilience, and segmentation-aligned strategies converge to sustain and advance cerebral angiography practice

Cerebral angiography remains a cornerstone of modern neurovascular care, positioned at the intersection of diagnostic precision and therapeutic capability. Technological advancements in digital imaging, software-enabled workflows, and catheter design are enabling safer, more efficient procedures while simultaneously expanding the clinical settings in which angiography can be deployed. However, external pressures such as trade policy shifts and regional infrastructure variability underscore the need for adaptable supply chains and service models.

Providers and suppliers that adopt a segmentation-aware approach-recognizing distinct requirements for fixed versus mobile systems, analog versus digital operation modes, diagnostic versus interventional applications, and differences among ambulatory centers and hospital types-will be best positioned to align investments with clinical and operational priorities. In short, the path forward demands coordinated action across technology innovation, supply chain resilience, and clinician-centered service delivery to ensure that angiographic capabilities continue to advance patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cerebral Angiography Market, by Equipment Type

  • 8.1. Fixed
  • 8.2. Mobile

9. Cerebral Angiography Market, by Operation Mode

  • 9.1. Analog
  • 9.2. Digital

10. Cerebral Angiography Market, by Application

  • 10.1. Diagnostic
  • 10.2. Interventional

11. Cerebral Angiography Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals

12. Cerebral Angiography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cerebral Angiography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cerebral Angiography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cerebral Angiography Market

16. China Cerebral Angiography Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. AngioDynamics, Inc.
  • 17.7. B. Braun Melsungen AG
  • 17.8. Bayer AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. Bracco Imaging S.p.A.
  • 17.12. Canon Medical Systems Corporation
  • 17.13. Cardinal Health, Inc.
  • 17.14. Carestream Health, Inc.
  • 17.15. Cook Group Incorporated
  • 17.16. GE Healthcare Technologies Inc.
  • 17.17. Guerbet S.A.
  • 17.18. Hitachi Medical Corporation
  • 17.19. Hologic, Inc.
  • 17.20. InterMed Medical Limited
  • 17.21. Koninklijke Philips N.V.
  • 17.22. MEDTRON AG
  • 17.23. Medtronic PLC
  • 17.24. Merit Medical Systems, Inc.
  • 17.25. MicroPort Scientific Corporation
  • 17.26. Penumbra, Inc.
  • 17.27. Samsung Medison Co., Ltd.
  • 17.28. Shimadzu Corporation
  • 17.29. Siemens Healthineers AG
  • 17.30. St. Stone Medical Devices Private Limited
  • 17.31. Stryker Corporation
  • 17.32. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY INTERVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 39. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 44. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 96. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GCC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 114. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. G7 CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 120. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NATO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY OPERATION MODE, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)